wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47251529-3C1DAA39-F38F-47D5-9C1C-D05D015157D7
Q47251529-3C1DAA39-F38F-47D5-9C1C-D05D015157D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47251529-3C1DAA39-F38F-47D5-9C1C-D05D015157D7
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.
P2860
Q47251529-3C1DAA39-F38F-47D5-9C1C-D05D015157D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47251529-3C1DAA39-F38F-47D5-9C1C-D05D015157D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba991fbcd0bd4dd85ce0161b46ab1b21325f9d0b
P2860
Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.